The results demonstrate a potential mechanism that underlies the tumor‐suppressor role of CISD2, and it is expected that screening for CISD2 expression combined with chemotherapy drugs will become a new therapeutic strategy for gastric cancer. This evidence concerns the gene CISD2 and neoplasm.